LNP-miR-155 cy5 Inhibitor Regulates the Copper Transporter via the β-Catenin/TCF4/SLC31A1 Signal for Colorectal Cancer Therapy.
暂无分享,去创建一个
Xiang Wang | Fan Jiang | Zhijue Chen | N. Liu | Dongsheng Ge | Le Du
[1] S. Ramakrishna,et al. Encapsulation of miRNA and siRNA into Nanomaterials for Cancer Therapeutics , 2022, Pharmaceutics.
[2] Xingjia Li,et al. Serum Copper and Zinc Levels and Colorectal Cancer in Adults: Findings from the National Health and Nutrition Examination 2011–2016 , 2021, Biological Trace Element Research.
[3] Zhenhua Zhu,et al. MiR‐155 promotes colitis‐associated intestinal fibrosis by targeting HBP1/Wnt/β‐catenin signalling pathway , 2021, Journal of cellular and molecular medicine.
[4] L. Sancey,et al. The Multifaceted Roles of Copper in Cancer: A Trace Metal Element with Dysregulated Metabolism, but Also a Target or a Bullet for Therapy , 2020, Cancers.
[5] A. Mannermaa,et al. MicroRNAs Associated With Biological Pathways of Left- and Right-sided Colorectal Cancer , 2020, AntiCancer Research.
[6] Yu Fu,et al. MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[7] H. Kang,et al. [Early-onset Colorectal Cancer]. , 2019, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.
[8] Jie Gu,et al. Inhibition of miR-155 Ameliorates Acute Kidney Injury by Apoptosis Involving the Regulation on TCF4/Wnt/β-Catenin Pathway , 2019, Nephron.
[9] R. Mehra,et al. TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer , 2019, bioRxiv.
[10] Weilin Wang,et al. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[11] Chunlin Zhao,et al. SAV1, regulated by microRNA-21, suppresses tumor growth in colorectal cancer. , 2019, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[12] M. Soleimani,et al. Potential using of microRNA-34A in combination with paclitaxel in colorectal cancer cells , 2019, Journal of cancer research and therapeutics.
[13] F. Wang,et al. MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer. , 2018, The international journal of biochemistry & cell biology.
[14] W. Harrington,et al. A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing. , 2018, Cell reports.
[15] A. Matheu,et al. Exosome-mediated breast cancer chemoresistance via miR-155 transfer , 2018, Scientific Reports.
[16] Xinke Zhou,et al. Reduced RCE1 expression predicts poor prognosis of colorectal carcinoma , 2017, BMC Cancer.
[17] A. Trovato-Salinaro,et al. Transcriptome analysis of copper homeostasis genes reveals coordinated upregulation of SLC31A1,SCO1, and COX11 in colorectal cancer , 2016, FEBS open bio.
[18] R. Vandenbroucke,et al. Comparing exosome-like vesicles with liposomes for the functional cellular delivery of small RNAs. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[19] Tao Li,et al. MicroRNA-155 enhances the activation of Wnt/β-catenin signaling in colorectal carcinoma by suppressing HMG-box transcription factor 1. , 2016, Molecular medicine reports.
[20] Delphine Denoyer,et al. Targeting copper in cancer therapy: 'Copper That Cancer'. , 2015, Metallomics : integrated biometal science.
[21] Y. Liu,et al. miR-155 promotes the growth of osteosarcoma in a HBP1-dependent mechanism , 2015, Molecular and Cellular Biochemistry.
[22] I. Wistuba,et al. Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer. , 2014, Lung cancer.
[23] D. Thiele,et al. Ctr2 regulates biogenesis of a cleaved form of mammalian Ctr1 metal transporter lacking the copper- and cisplatin-binding ecto-domain , 2013, Proceedings of the National Academy of Sciences.
[24] Dan Li,et al. Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling. , 2013, The Journal of clinical endocrinology and metabolism.
[25] A. Hecht,et al. Acetylation of Human TCF4 (TCF7L2) Proteins Attenuates Inhibition by the HBP1 Repressor and Induces a Conformational Change in the TCF4::DNA Complex , 2013, PloS one.
[26] Tao Gong,et al. Systemic delivery of microRNA-34a for cancer stem cell therapy. , 2013, Angewandte Chemie.
[27] Weihong Tan,et al. A liposome-based nanostructure for aptamer directed delivery. , 2010, Chemical communications.
[28] Kathryn A. Whitehead,et al. Lipid-like materials for low-dose, in vivo gene silencing , 2010, Proceedings of the National Academy of Sciences.
[29] Yi Lu,et al. Reversible cell-specific drug delivery with aptamer-functionalized liposomes. , 2009, Angewandte Chemie.
[30] D. Kimelman,et al. β-Catenin destruction complex: insights and questions from a structural perspective , 2006, Oncogene.
[31] Chris Albanese,et al. Negative regulation of the Wnt–β‐catenin pathway by the transcriptional repressor HBP1 , 2001, The EMBO journal.
[32] N. Singh,et al. Anticancer Potency of Copper(I) Complexes Against a Range Cancer Cell Lines: A Review , 2021 .
[33] George A. Calin,et al. RNA interference in the clinic: challenges and future directions , 2011, Nature Reviews Cancer.